Targeted tumor therapy remixed—an update on the use of small-molecule drugs in combination therapies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cancers ; 10 (2018), 6. - Art.-Nr. 155. - eISSN 2072-6694
- Keyword
-
Krebs
Melanom
Immuntherapie
Metabolomik
- Event
-
Veröffentlichung
- (where)
-
Ulm
- (who)
-
Universität Ulm
- (when)
-
2018
- Creator
-
Gatzka, Martina V.
- DOI
-
10.18725/OPARU-39522
- URN
-
urn:nbn:de:bsz:289-oparu-39598-0
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:43 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gatzka, Martina V.
- Universität Ulm
Time of origin
- 2018
Other Objects (12)
"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom
Nanomedicine formulations for combination therapies
Combination therapies to enhance the efficacy of PSMA-targeted radioligand therapy in prostate cancer
Developing targeted therapies for pediatric PFA ependymoma
Prostate cancer stem cells: Clinical aspects and targeted therapies
Mouse models and targeted therapies for RAS-driven tumours
Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors
Targeted therapies for the treatment of triple-negative breast cancer
Network meta-analysis for the integrated evaluation of targeted therapies
Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis
Antitumoral polymeric siRNA nanoformulation and pretubulysin-based combination therapies
Therapeutic concepts : Proposing a new regulatory pathway for combination therapies
"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom
Nanomedicine formulations for combination therapies
Combination therapies to enhance the efficacy of PSMA-targeted radioligand therapy in prostate cancer
Developing targeted therapies for pediatric PFA ependymoma
Prostate cancer stem cells: Clinical aspects and targeted therapies
Mouse models and targeted therapies for RAS-driven tumours
Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors
Targeted therapies for the treatment of triple-negative breast cancer
Network meta-analysis for the integrated evaluation of targeted therapies
Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis
Antitumoral polymeric siRNA nanoformulation and pretubulysin-based combination therapies
Therapeutic concepts : Proposing a new regulatory pathway for combination therapies
"Targeted therapies" beim nichtkleinzelligen Bronchialkarzinom
Nanomedicine formulations for combination therapies
Combination therapies to enhance the efficacy of PSMA-targeted radioligand therapy in prostate cancer
Developing targeted therapies for pediatric PFA ependymoma
Prostate cancer stem cells: Clinical aspects and targeted therapies
Mouse models and targeted therapies for RAS-driven tumours
Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors
Targeted therapies for the treatment of triple-negative breast cancer
Network meta-analysis for the integrated evaluation of targeted therapies
Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis
Antitumoral polymeric siRNA nanoformulation and pretubulysin-based combination therapies